Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 92

Thestrup joins Angelini Pharma's CVC unit

Angelini Pharma has hired Thomas Michael Thestrup, formerly of UCB and Lundbeck, to work on its innovation team.

Jan 26, 2022

Daily Deal Round Up: January 25, 2022

Anhui Jiangnan Construction Investment Group helped commercial rocket developer Galactic Energy secure $200m while off-road vehicle developer Rox raised $100m in a Tencent-led round.

Jan 25, 2022

Pluto to merge with NFT Investments

Argo Blockchain is set to exit cryptocurrency technology developer Pluto Digital in a reverse takeover, as Blockchain Founders Fund gets corporate help for a $75m fund.

Jan 25, 2022

Daily Deal Round Up: January 24, 2022

Razorpay is reportedly eyeing the possibility of acquiring Amex-backed Ezetap while Sayata and Spectrum Labs were among the companies that received corporate backing.

Jan 24, 2022

Daily Deal Round Up: January 21, 2022

SoftBank Vision Fund 2 helped revenue growth technology provider 6sense close a $200m series E round at a $5.2bn valuation, cash used to acquire Gree-backed sales software developer Saleswhale.

Jan 21, 2022

Deals: January 21, 2022

Every day, Global University Venturing rounds up investments from across the university innovation ecosystem in its deal net.

Jan 21, 2022

Daily Deal Round Up: January 20, 2022

Mental health app developer Lyra Health raised $235m from investors including Salesforce while blockchain development software provider Secret Network launched a $225m ecosystem fund.

Jan 20, 2022

Mythical Games scores Polystream acquisition

Intel and Wargaming Group both exited the metaverse gaming platform developer in a deal which could be the first of several in the rapidly growing space.

Jan 20, 2022

Deals: January 20, 2022

Every day, Global University Venturing rounds up investments from across the university innovation ecosystem in its deal net.

Jan 20, 2022

Ori Biotech orchestrates series B

UCL spinout Ori Biotech has raised more than $100m in a series B round led by Novalis LifeSciences, just over a year after closing a $30m series A round.

Jan 20, 2022
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here